DEANNA ZIMKUS: Open Payments
NPI 1710211370 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 39 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $826 · 2025 $1,156
Food & beverage: $1,076Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $270 |
| Galderma Laboratories, L.P. | 8 | $252 |
| UCB, Inc. | 4 | $191 |
| ABBVIE INC. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| REVANCE THERAPEUTICS, INC. | 2 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Lilly USA, LLC | 2 | $48 |
| GENZYME CORPORATION | 1 | $27 |
| Incyte Corporation | 1 | $23 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, DUPIXENT, DAXXIFY, Sotyktu, RINVOQ, EBGLYSS.
Industry payments across CT — which companies pay providers there.
